New method inserts long DNA segments at precise genome locations
Researchers at Boston Children's Hospital developed a technique called prime assembly that builds on prime editing to insert DNA fragments up to 12.1 kilobases at specific genome sites. The method uses single-stranded DNA flaps to control exactly where the replacement starts and ends, potentially addressing genetic diseases caused by many mutations. The approach is still early but could enable mutation-agnostic therapies.
Prime assembly was developed at Boston Children's Hospital and published in Nature. The technique creates single-stranded DNA flaps at chosen genomic positions, which guide the integration of DNA segments up to 12.1 kilobases in size—large enough to contain entire gene fragments. This allows a single editing step to produce a permanent genetic change.
The method proved effective in both dividing and non-dividing cells, and in some comparisons it outperformed existing targeted integration techniques. Unlike certain current approaches, prime assembly avoids deliberately creating double-strand breaks, which can stress cells. The research remains preclinical, with experiments conducted in cell lines and primary cells from healthy donors, and delivery methods for use inside living organisms have yet to be developed.
If prime assembly advances beyond preclinical testing, it could offer a unified strategy for genetic diseases caused by many different mutations, potentially benefiting patients with inherited blood disorders and other conditions lacking tailored treatments. Because the method works in non-dividing cells, it may reach tissues that current approaches cannot. However, delivery challenges and off-target risks remain unresolved, and clinical application is likely years away. The technology's ultimate societal impact will depend on safety, efficiency, and accessibility of any eventual therapies.